Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yakult Honsha Co., Ltd. (2267:JPX), powered by AI.
Yakult Honsha Co., Ltd. is currently trading at ¥2,645.5. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Yakult Honsha Co., Ltd. on Alpha Lenz.
Yakult Honsha Co., Ltd.'s P/E ratio is 17.6.
“Yakult Honsha Co., Ltd. trades at a P/E of 17.6 (fair value) with solid ROE of 8.1%.”
Ask for details →Yakult Honsha Co., Ltd. is a Japanese multinational corporation that primarily focuses on the production and sale of probiotic beverages, most notably under the "Yakult" brand. The primary function of Yakult Honsha Co., Ltd. is to promote digestive health and wellness through its probiotic products. Known for its flagship probiotic drink which contains a unique strain of bacteria, Lactobacillus casei Shirota, the company has established a significant presence in both domestic and international markets. Yakult's products have a strong impact on the functional foods and health beverages sector, underscoring the growing consumer demand for health-oriented dietary supplements. This focus on health and wellness has positioned Yakult Honsha as a key player in the global probiotics market. Established in 1955 and headquartered in Tokyo, the company branches into pharmaceuticals, cosmetics, and other health-related products, making it a diversified entity in the consumer products and healthcare industries. Its significant role in the market is highlighted by its expansive distribution channels and its commitment to scientific research and education in probiotics and overall health.
“Yakult Honsha Co., Ltd. trades at a P/E of 17.6 (fair value) with solid ROE of 8.1%.”
Ask for details →Yakult Honsha Co., Ltd. (ticker: 2267) is a company listed on JPX in the Consumer Defensive sector (Beverages - Non-Alcoholic). It has approximately 29,254 employees. Market cap is $800.5B.
The current price is 2,645.5 with a P/E ratio of 17.58x and P/B of 1.39x.
ROE is 8.11% and operating margin is 11.09%. Annual revenue is $499.7B.